Real-world insights into risk of developing cardiovascular disease following GnRH agonists versus antagonists for prostate cancer a methodological protocol to a study using five European databases - Université de Rennes Accéder directement au contenu
Article Dans Une Revue Fundamental & Clinical Pharmacology Année : 2019

Real-world insights into risk of developing cardiovascular disease following GnRH agonists versus antagonists for prostate cancer a methodological protocol to a study using five European databases

Fichier principal
Vignette du fichier
George_et_al-2019-Real‐world insights into risk of developing cardiovascular disease.pdf (1.08 Mo) Télécharger le fichier
Origine : Publication financée par une institution
Loading...

Dates et versions

hal-02055724 , version 1 (17-04-2019)

Licence

Paternité - Pas d'utilisation commerciale - Pas de modification

Identifiants

Citer

Gincy George, Lucie-Marie Scailteux, Hans Garmo, Frédéric Balusson, Christopher Cardwell, et al.. Real-world insights into risk of developing cardiovascular disease following GnRH agonists versus antagonists for prostate cancer a methodological protocol to a study using five European databases. Fundamental & Clinical Pharmacology, 2019, 33 (4), pp.479-499. ⟨10.1111/fcp.12454⟩. ⟨hal-02055724⟩
75 Consultations
74 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More